Literature DB >> 11483761

Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection.

D A Dodd1, T H Giddings, K Kirkegaard.   

Abstract

During viral infections, the host secretory pathway is crucial for both innate and acquired immune responses. For example, the export of most proinflammatory and antiviral cytokines, which recruit lymphocytes and initiate antiviral defenses, requires traffic through the host secretory pathway. To investigate potential effects of the known inhibition of cellular protein secretion during poliovirus infection on pathogenesis, cytokine secretion from cells infected with wild-type virus and with 3A-2, a mutant virus carrying an insertion in viral protein 3A which renders the virus defective in the inhibition of protein secretion, was tested. We show here that cells infected with 3A-2 mutant virus secrete greater amounts of cytokines interleukin-6 (IL-6), IL-8, and beta interferon than cells infected with wild-type poliovirus. Increased cytokine secretion from the mutant-infected cells can be attributed to the reduced inhibition of host protein secretion, because no significant differences between 3A-2- and wild-type-infected cells were observed in the inhibition of viral growth, host cell translation, or the ability of wild-type- or 3A-2-infected cells to support the transcriptional induction of beta interferon mRNA. We surmise that the wild-type function of 3A in inhibiting ER-to-Golgi traffic is not required for viral replication in tissue culture but, by altering the amount of secreted cytokines, could have substantial effects on pathogenesis within an infected host. The global inhibition of protein secretion by poliovirus may reflect a general mechanism by which pathogens that do not require a functional protein secretory apparatus can reduce the native immune response and inflammation associated with infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483761      PMCID: PMC115060          DOI: 10.1128/jvi.75.17.8158-8165.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Structure and function of the interferon-beta enhanceosome.

Authors:  T Maniatis; J V Falvo; T H Kim; T K Kim; C H Lin; B S Parekh; M G Wathelet
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1998

Review 2.  High-pressure freezing for the preservation of biological structure: theory and practice.

Authors:  R Dahl; L A Staehelin
Journal:  J Electron Microsc Tech       Date:  1989-11

3.  Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells.

Authors:  J Lama; M A Sanz; L Carrasco
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

Review 4.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region.

Authors:  K Bienz; D Egger; M Troxler; L Pasamontes
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Isolation of poliovirus 2C mutants defective in viral RNA synthesis.

Authors:  J P Li; D Baltimore
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 7.  Regulation of interleukin-8 gene expression.

Authors:  K A Roebuck
Journal:  J Interferon Cytokine Res       Date:  1999-05       Impact factor: 2.607

8.  Effect on platelet-derived growth factor-induced mitogenesis of double-stranded RNA: evidence for an autocrine growth inhibition mediated by interferon-beta.

Authors:  K Forsberg; Y Paulsson; B Westermark
Journal:  J Cell Physiol       Date:  1988-08       Impact factor: 6.384

9.  Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro.

Authors:  P Yalamanchili; K Weidman; A Dasgupta
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

10.  Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis.

Authors:  H D Berstein; D Baltimore
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  87 in total

1.  Intracellular topology and epitope shielding of poliovirus 3A protein.

Authors:  Sunny S Choe; Karla Kirkegaard
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

3.  Poliovirus unlinks TIA1 aggregation and mRNA stress granule formation.

Authors:  James P White; Richard E Lloyd
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Dendritic cells and macrophages are productively infected by poliovirus.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle.

Authors:  Christopher T Cornell; William B Kiosses; Stephanie Harkins; J Lindsay Whitton
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Hijacking components of the cellular secretory pathway for replication of poliovirus RNA.

Authors:  George A Belov; Nihal Altan-Bonnet; Gennadiy Kovtunovych; Catherine L Jackson; Jennifer Lippincott-Schwartz; Ellie Ehrenfeld
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication.

Authors:  George A Belov; Courtney Habbersett; David Franco; Ellie Ehrenfeld
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 8.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

Review 9.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

10.  A Redundant Mechanism of Recruitment Underlies the Remarkable Plasticity of the Requirement of Poliovirus Replication for the Cellular ArfGEF GBF1.

Authors:  Ekaterina G Viktorova; Samuel Gabaglio; Justyna M Meissner; Eunjoo Lee; Seyedehmahsa Moghimi; Elizabeth Sztul; George A Belov
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.